Peter McCaffrey, Ronald Jackups, Jansen Seheult, Mark A Zaydman, Ulysses Balis, Harshwardhan M Thaker, Hooman Rashidi, Rama R Gullapalli
{"title":"Evaluating Use of Generative Artificial Intelligence in Clinical Pathology Practice: Opportunities and the Way Forward.","authors":"Peter McCaffrey, Ronald Jackups, Jansen Seheult, Mark A Zaydman, Ulysses Balis, Harshwardhan M Thaker, Hooman Rashidi, Rama R Gullapalli","doi":"10.5858/arpa.2024-0208-RA","DOIUrl":null,"url":null,"abstract":"<p><strong>Context.—: </strong>Generative artificial intelligence (GAI) technologies are likely to dramatically impact health care workflows in clinical pathology (CP). Applications in CP include education, data mining, decision support, result summaries, and patient trend assessments.</p><p><strong>Objective.—: </strong>To review use cases of GAI in CP, with a particular focus on large language models. Specific examples are provided for the applications of GAI in the subspecialties of clinical chemistry, microbiology, hematopathology, and molecular diagnostics. Additionally, the review addresses potential pitfalls of GAI paradigms.</p><p><strong>Data sources.—: </strong>Current literature on GAI in health care was reviewed broadly. The use case scenarios for each CP subspecialty review common data sources generated in each subspecialty. The potential for utilization of CP data in the GAI context was subsequently assessed, focusing on issues such as future reporting paradigms, impact on quality metrics, and potential for translational research activities.</p><p><strong>Conclusions.—: </strong>GAI is a powerful tool with the potential to revolutionize health care for patients and practitioners alike. However, GAI must be implemented with much caution considering various shortcomings of the technology such as biases, hallucinations, practical challenges of implementing GAI in existing CP workflows, and end-user acceptance. Human-in-the-loop models of GAI implementation have the potential to revolutionize CP by delivering deeper, meaningful insights into patient outcomes both at an individual and population level.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of pathology & laboratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5858/arpa.2024-0208-RA","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Context.—: Generative artificial intelligence (GAI) technologies are likely to dramatically impact health care workflows in clinical pathology (CP). Applications in CP include education, data mining, decision support, result summaries, and patient trend assessments.
Objective.—: To review use cases of GAI in CP, with a particular focus on large language models. Specific examples are provided for the applications of GAI in the subspecialties of clinical chemistry, microbiology, hematopathology, and molecular diagnostics. Additionally, the review addresses potential pitfalls of GAI paradigms.
Data sources.—: Current literature on GAI in health care was reviewed broadly. The use case scenarios for each CP subspecialty review common data sources generated in each subspecialty. The potential for utilization of CP data in the GAI context was subsequently assessed, focusing on issues such as future reporting paradigms, impact on quality metrics, and potential for translational research activities.
Conclusions.—: GAI is a powerful tool with the potential to revolutionize health care for patients and practitioners alike. However, GAI must be implemented with much caution considering various shortcomings of the technology such as biases, hallucinations, practical challenges of implementing GAI in existing CP workflows, and end-user acceptance. Human-in-the-loop models of GAI implementation have the potential to revolutionize CP by delivering deeper, meaningful insights into patient outcomes both at an individual and population level.
背景:生成人工智能(GAI)技术可能会对临床病理学(CP)的医疗保健工作流程产生巨大影响。临床病理学中的应用包括教育、数据挖掘、决策支持、结果摘要和患者趋势评估:回顾 GAI 在临床病理学中的使用案例,尤其关注大型语言模型。提供 GAI 在临床化学、微生物学、血液病理学和分子诊断等亚专科应用的具体实例。此外,该综述还探讨了 GAI 范例的潜在缺陷:广泛查阅了当前有关医疗保健领域 GAI 的文献。每个 CP 亚专科的用例方案审查了每个亚专科产生的常见数据源。随后评估了在 GAI 背景下利用 CP 数据的潜力,重点关注未来报告范例、对质量指标的影响以及转化研究活动的潜力等问题:GAI 是一个强大的工具,有可能为患者和从业人员带来医疗保健的革命性变化。然而,考虑到该技术的各种缺陷,如偏差、幻觉、在现有 CP 工作流程中实施 GAI 的实际挑战以及最终用户的接受程度,GAI 的实施必须非常谨慎。实施 GAI 的 "人在回路中 "模式有可能在个人和群体层面提供对患者预后更深入、更有意义的见解,从而彻底改变心肺复苏术。